Journal: Molecular microbiology
Article Title: Salmonella enterica synthesizes 5,6-dimethylbenzimidazolyl-(DMB)-?-riboside. Why some Firmicutes do not require the canonical DMB activation system to synthesize adenosylcobalamin.
PMID/MRN: 27748967
Publication Date: 2016-Oct-17
Abstract:
5,6-Dimethylbenzimidazolyl-(DMB)-?-ribotide [?-ribazole-5'-phosphate (?-RP)] is an intermediate in the biosynthesis of adenosylcobalamin (AdoCbl) in many prokaryotes. In such microbes, ?-RP is synthesized by nicotinate mononucleotide (NaMN):DMB phosphoribosyltransferases (CobT in Salmonella enterica), in a reaction that is considered to be the canonical step for the activation of the base of the nucleotide present in adenosylcobamides. Some Firmicutes lack CobT-type enzymes but have a two-protein system comprised of a transporter (i.e., CblT) and a kinase (i.e., CblS) that can salvage exogenous ?-ribazole (?-R) from the environment using CblT to take up ?-R, followed by ?-R phosphorylation by CblS. We report that Geobacillus kaustophilus CblT and CblS proteins restore ?-RP synthesis in S. enterica lacking the CobT enzyme. We also show that a S. enterica cobT strain that synthesizes GkCblS ectopically makes only AdoCbl, even under growth conditions where the synthesis of pseudoCbl is favored. Our results indicate that S. enterica synthesizes ?-R, a metabolite that had not been detected in this bacterium and that GkCblS has a strong preference for DMB-ribose over adenine-ribose as substrate. We propose that in some Firmicutes DMB is activated to ?-RP via ?-R using an as-yet-unknown route to convert DMB to ?-R and CblS to convert ?-R to ?-RP.
© 2016 John Wiley & Sons Ltd.